Analyst Expect Big Moves From Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC)
Currently, there are 22.27M common shares owned by the public and among those 22.27M shares have been available to trade. The company’s stock has a 5-day price change of 25.68% and -92.78% over the past three months. CYCC shares are trading -94.18% year to date (YTD), with the 12-month market performance down to -98.67% lower. […]
Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC): Stock That Needs Special Handling
Currently, there are 12.96M common shares owned by the public and among those 10.41M shares have been available to trade. The company’s stock has a 5-day price change of -78.98% and -92.99% over the past three months. CYCC shares are trading -94.27% year to date (YTD), with the 12-month market performance down to -98.98% lower. […]
Some Investing Thoughts On Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC)
Cyclacel Pharmaceuticals Inc (CYCC) concluded trading on Thursday at a closing price of $0.61, with 5.48 million shares of worth about $3.34 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -90.78% during that period and on Thursday the price saw a loss of […]